Table 2.
TPS <50% (reference) vs TPS ≥50% | ||||||
Variables | All subtypes | Non-squamous NSCLC | LUSC | |||
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
Age | ||||||
<50 years | Reference | 0.737 | Reference | 0.711 | Reference | 0.046* |
≥50 years | 0.97 (0.82 to 1.15) | 1.03 (0.86 to 1.24) | 0.61 (0.37 to 0.99) | |||
Gender | ||||||
Male | Reference | 0.027* | Reference | 0.184 | Reference | 0.015* |
Female | 1.08 (1.01 to 1.16) | 1.05 (0.98 to 1.14) | 1.23 (1.04 to 1.44) | |||
Bx site | ||||||
Primary | Reference | <0.001* | Reference | <0.001* | Reference | 0.197 |
Metastatic | 1.28 (1.19 to 1.37) | 1.37 (1.27 to 1.49) | 0.89 (0.74 to 1.06) | |||
Primary (reference) vs metastatic site | ||||||
Lymph node | 1.58 (1.43 to 1.74) | <0.001* | 1.80 (1.61 to 2.00) | <0.001* | 0.83 (0.63 to 1.08) | 0.163 |
Liver | 0.98 (0.83 to 1.16) | 0.835 | 1.03 (0.86 to 1.24) | 0.75 | 1.21 (0.79 to 1.87) | 0.385 |
Brain | 1.00 (0.85 to 1.18) | 0.994 | 1.02 (0.85 to 1.21) | 0.842 | 0.96 (0.51 to 1.81) | 0.903 |
Pleural fluid | 1.48 (1.23 to 1.78) | <0.001* | 1.53 (1.27 to 1.84) | <0.001* | 0 (0 to 3.24e+166) | 0.95 |
Soft tissue | 1.30 (1.08 to 1.58) | 0.007* | 1.44 (1.17 to 1.79) | 0.001* | 0.92 (0.58 to 1.47) | 0.73 |
Bone | 0.83 (0.67 to 1.04) | 0.101 | 0.81 (0.64 to 1.02) | 0.073 | 0.87 (0.45 to 1.69) | 0.684 |
Pleura | 1.12 (0.89 to 1.40) | 0.343 | 1.14 (0.89 to 1.45) | 0.288 | 0.83 (0.39 to 1.77) | 0.628 |
Adrenal gland | 1.70 (1.30 to 2.22) | <0.001* | 1.66 (1.24 to 2.21) | 0.001* | 2.04 (0.87 to 4.76) | 0.1 |
*p < 0.05
LUSC, lung squamous cell carcinoma; NSCLC, non-small cell lung cancer; TPS, tumor proportion score.